#95 Landmark Clinical Evidence
Peer-reviewed human research with direct implications for cannabis medicine practice.
๐ผ As cannabis legalization continues to expand across jurisdictions, healthcare providers should recognize that legal status varies significantly by state and region, creating a complex landscape for patient counseling and documentation. While prohibition tags and legal classifications may seem administrative, they reflect underlying regulatory frameworks that influence product quality standards, testing requirements, and medical evidence availability in different markets. Providers should remain aware that patients may have access to cannabis products with vastly different safety profiles and potency levels depending on their location, and that state-level legal protections for cannabis use may not extend to federal employment, housing, or child custody contexts. These regulatory inconsistencies can complicate clinical decision-making, particularly when advising patients with chronic pain, anxiety, or other conditions for which cannabis is increasingly sought. In practice, clinicians should counsel patients on both the legal landscape in their specific jurisdiction and the gaps in evidence-based dosing and safety data, while documenting discussions carefully to protect patients from potential legal
💬 Join the Conversation
Have a question about how this applies to your situation? Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers? Join the forum discussion →
Have thoughts on this? Share it: